Test drug QSant™ to detect early kidney transplant rejection
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This study tests QSant™ in people who are within 90 days after a kidney transplant. It aims to help detect or understand rejection of the transplanted kidney early, which could improve how doctors manage care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had a kidney transplant within the last 90 days
- Your transplant may be combined with other organs as long as kidney is included
- You can understand the study and sign informed consent
- You can follow all study visits and instructions
- You can provide a urine sample each time it is collected
- You do not have certain bladder/urine outflow conditions (like vesicostomy or special urine pathways)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special urine test can detect kidney problems early in people who have had a kidney transplant or who have chronic or acute kidney disease. It requires a first-morning urine sample and regular check-ups at the study hospital.
This trial is testing a new blood test (called TreaT-Assay) to help diagnose acute rejection after a kidney transplant. The goal is to catch rejection earlier and more accurately, so you can get the right treatment faster.
This study is for people with a kidney transplant who are in the hospital for a biopsy because their doctor suspects rejection. Researchers want to see if a simple blood or urine test can detect rejection, which might make future biopsies less necessary.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This study looks for pieces of kidney DNA in the blood of people who have a kidney transplant and need a biopsy. The goal is to see if this test can help doctors know if the kidney is being rejected without needing a biopsy.
This trial checks if a new urine test (u DKK3) can find signs of kidney transplant problems earlier than current tests. It looks at your kidney function over the first year after your transplant.
Hear when a new Kidney Transplant Failure and Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.